On (b)(6) 2015, a call was received from a customer alleging a variance in a patient's inratio2 inr results.On (b)(6) 2015, the patient's inratio2 was 1.8.It is unknown if there was a medication adjustment after the 1.8 result or what the patient's therapeutic range was.Later in the week, the inratio was approximately 6.0 - 7.0.The warfarin was held over the weekend and the laboratory inr was 1.4 on (b)(6) 2015.Though requested, there was no additional information provided.
|
Investigation/conclusion: the customer did not provide a laboratory reference value for comparison.The accuracy of the inratio results cannot be determined without this information.It is indicated that the product is not returning for evaluation.Since the product associated with the complaint was not returned, a review of in-house testing was performed.The retain strip testing results met both accuracy and strip repeatability criteria.The product performed as expected and no product deficiencies were observed.A review of the manufacturing records for the lot did not uncover any relevant non-conformances and the lot met release specification.The root cause is unable to be determined from the information provided.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
|